988105680	988105680	CD	B-NP	O
|	|	NN	I-NP	O
PRH	PRH	NN	I-NP	O
|	|	NN	I-NP	O
21384952	21384952	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
294487	294487	CD	B-NP	O
|	|	CC	I-NP	O
6/6/1998	6/6/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
R/O	R/O	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/2/1998	10/2/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/27/1998	11/27/1998	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
WIDE	WIDE	NN	B-NP	O
COMPLEX	COMPLEX	NN	I-NP	O
TACHYCARDIA	TACHYCARDIA	NN	I-NP	O
POST	POST	NN	I-NP	O
EXERCISE	EXERCISE	NN	I-NP	O
TOLERANCE	TOLERANCE	NN	I-NP	O
TEST	TEST	NN	I-NP	O
RECOVERY	RECOVERY	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
HYPERCOAGULABILITY	HYPERCOAGULABILITY	NNP	I-NP	O
STATE	STATE	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
NEGATIVE	NEGATIVE	NNP	I-NP	O
SERUM	SERUM	NNP	I-NP	O
WORK-UP	WORK-UP	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RULE	RULE	NNP	I-NP	O
OUT	OUT	NNP	I-NP	O
RENAL	RENAL	NNP	I-NP	O
CELL	CELL	NNP	I-NP	O
CARCINOMA	CARCINOMA	NNP	I-NP	O
ON	ON	NNP	I-NP	O
THE	THE	DT	B-NP	O
LEFT	LEFT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CT	CT	NN	I-NP	O
PENDING	PENDING	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HISTORY	HISTORY	NN	I-NP	B-protein
OF	OF	IN	B-PP	I-protein
PPD	PPD	NNP	B-NP	O
POSITIVITY	POSITIVITY	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
CHEST	CHEST	NNP	I-NP	O
X-RAY	X-RAY	NNP	I-NP	O
NEGATIVE	NEGATIVE	NNP	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GOUT	GOUT	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHRONIC	CHRONIC	NNP	I-NP	O
OBSTRUCTIVE	OBSTRUCTIVE	NNP	I-NP	O
PULMONARY	PULMONARY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
POST	POST	NNP	I-NP	O
UNILATERAL	UNILATERAL	NNP	I-NP	O
ORCHIECTOMY	ORCHIECTOMY	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
HEPATITIS	HEPATITIS	NN	B-NP	B-protein
A.	A.	NN	I-NP	I-protein
HISTORY	HISTORY	NN	I-NP	I-protein
OF	OF	IN	B-PP	I-protein
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
,	,	,	O	O
remote	remote	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypercoagulability	hypercoagulability	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
work-up	work-up	NN	I-NP	O
for	for	IN	B-PP	O
protein	protein	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
S	S	NN	B-NP	O
,	,	,	O	O
activated	activate	VBN	B-NP	O
protein	protein	NN	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
factor	factor	NN	B-NP	O
V	V	NN	I-NP	O
lydin	lydin	NN	I-NP	O
,	,	,	O	O
antithrombin	antithrombin	NN	B-NP	B-protein
III	III	CD	I-NP	I-protein
,	,	,	O	O
anticardiolipin	anticardiolipin	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
homocystine	homocystine	NN	B-NP	B-protein
level	level	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thromboses/pulmonary	thromboses/pulmonary	JJ	I-NP	O
emboli	embolus	NNS	I-NP	O
requiring	require	VBG	B-VP	O
chronic	chronic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
and	and	CC	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
11/20	11/20	CD	B-NP	O
He	He	PRP	B-NP	O
reportedly	reportedly	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
6/10	6/10	CD	B-NP	O
through	through	IN	B-PP	O
3/11/98	3/11/98	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Holter	Holter	NNP	I-NP	O
monitor	monitor	NN	I-NP	O
in	in	IN	B-PP	O
4/17	4/17	CD	B-NP	O
showed	show	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
,	,	,	O	O
21	21	CD	B-NP	O
couplets	couplet	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
10/28	10/28	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
prolapse	prolapse	NN	I-NP	O
with	with	IN	B-PP	O
2-3	2-3	NN	B-NP	O
+	+	CC	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
trace	trace	VB	B-VP	O
aortic	aortic	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
Holter	Holter	NN	I-NP	O
in	in	IN	B-PP	O
3/15	3/15	CD	B-NP	O
showed	show	VBD	B-VP	O
numerous	numerous	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
,	,	,	O	O
PM	PM	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
113	113	CD	B-NP	O
,	,	,	O	O
six	six	CD	B-NP	O
triplets	triplet	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
172	172	CD	B-NP	O
couplets	couplet	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
4/4	4/4	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
lasted	last	VBD	B-VP	O
two	two	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
atypical	atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
79	79	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
170	170	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
definite	definite	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
clinically	clinically	RB	I-NP	O
significant	significant	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
disturbance	disturbance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
a	a	DT	B-NP	O
vague	vague	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmia	arrhythmia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Oven	Oven	NNP	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
supposedly	supposedly	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placed	place	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
ever	ever	RB	I-VP	O
being	be	VBG	I-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
reported	report	VBN	I-VP	O
increasing	increase	VBG	B-VP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
way	way	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
check	check	NN	I-NP	I-protein
,	,	,	O	O
he	he	PRP	B-NP	O
reported	report	VBD	B-VP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
emboli	embolus	NNS	I-NP	O
,	,	,	O	O
apparently	apparently	RB	B-ADVP	O
10/10	10/10	CD	B-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
though	though	IN	B-SBAR	O
he	he	PRP	B-NP	O
denied	deny	VBD	B-VP	O
it	it	PRP	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
with	with	IN	B-PP	O
``	``	``	O	O
heavy	heavy	JJ	B-NP	O
heart	heart	NN	I-NP	O
beats	beat	NNS	I-NP	O
''	''	''	O	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
associated	associate	VBN	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
light	light	JJ	B-NP	O
headedness	headedness	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
syncopal	syncopal	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
flat	flat	JJ	B-NP	O
CK	CK	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
0	0	CD	I-NP	O
troponin	troponin	NN	I-NP	O
I	I	CD	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
lasting	last	VBG	B-VP	O
three	three	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
fifteen	fifteen	CD	B-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
and	and	CC	B-NP	O
not	not	RB	I-NP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
five	five	CD	I-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
recovery	recovery	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
nonmonomorphic	nonmonomorphic	JJ	B-NP	O
wide	wide	JJ	I-NP	O
complex	complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
150	150	CD	I-NP	O
lasting	last	VBG	B-VP	O
twenty	twenty	CD	B-NP	O
to	to	TO	I-NP	O
thirty	thirty	CD	I-NP	O
beats	beat	NNS	I-NP	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
reportedly	reportedly	RB	B-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
possible	possible	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
emboli/deep	emboli/deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thromboses	thrombos	NNS	I-NP	O
with	with	IN	B-PP	O
number	number	NN	B-NP	O
one	one	CD	I-NP	O
in	in	IN	B-PP	O
11/17	11/17	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
TPA	TPA	NN	I-NP	O
when	when	WRB	B-ADVP	O
echo	echo	NN	B-NP	O
showed	show	VBD	B-VP	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
number	number	NN	B-NP	O
two	two	CD	I-NP	O
in	in	IN	B-PP	O
6/28	6/28	CD	B-NP	O
,	,	,	O	O
number	number	NN	B-NP	O
three	three	CD	I-NP	O
in	in	IN	B-PP	O
6/10	6/10	CD	B-NP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
number	number	NN	B-NP	O
four	four	CD	I-NP	O
in	in	IN	B-PP	O
2/11	2/11	CD	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
placement	placement	NN	I-NP	O
when	when	WRB	B-ADVP	O
patient	patient	NN	B-NP	O
bled	bleed	VBD	B-VP	O
into	into	IN	B-PP	O
left	left	JJ	B-NP	O
renal	renal	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	B-PP	O
3.8	3.8	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
hypercoagulability	hypercoagulability	NN	I-NP	O
work-up	work-up	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
which	which	WDT	B-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
PPD	PPD	NN	B-NP	O
positivity	positivity	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
cm	cm	NN	I-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
prolapse	prolapse	NN	I-NP	O
and	and	CC	I-NP	O
MR	MR	NN	I-NP	B-protein
on	on	IN	B-PP	O
echo	echo	JJ	B-NP	O
,	,	,	I-NP	O
hypertensive	hypertensive	JJ	I-NP	O
borderline	borderline	JJ	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
unilateral	unilateral	JJ	I-NP	O
orchiectomy	orchiectomy	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
duplex	duplex	NN	I-NP	O
5	5	CD	I-NP	O
cm	cm	NN	I-NP	O
adrenal	adrenal	JJ	I-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
17	17	CD	I-NP	O
hydroxyketosteroids	hydroxyketosteroid	NNS	I-NP	O
and	and	CC	I-NP	O
VMA	VMA	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
A	A	NN	I-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O

CURRENT	CURRENT	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Cardura	Cardura	NNP	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Axid	Axid	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
6	6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
indomethacin	indomethacin	NN	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
gout	gout	NN	B-NP	O
exacerbations	exacerbation	NNS	I-NP	O
and	and	CC	O	O
ace	ace	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
beta	beta	SYM	B-NP	O
blocker	blocker	NN	I-NP	O
with	with	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
retention	retention	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cancer	cancer	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
premature	premature	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
sudden	sudden	JJ	B-NP	O
death	death	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
immigrated	immigrate	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Georgia	Georgia	NNP	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
remote	remote	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
,	,	,	O	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
factory	factory	NN	I-NP	O
worker	worker	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Negative	Negative	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
70	70	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
borderline	borderline	JJ	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercoagulability	hypercoagulability	NN	B-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
emboli	embolus	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
asymptomatically	asymptomatically	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
complex	complex	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
Holter	Holter	NNP	B-NP	O
monitoring	monitor	VBG	B-VP	O
times	time	NNS	B-NP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
lowering	lower	VBG	B-VP	O
agent	agent	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
Heparin	Heparin	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
invasive	invasive	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/15/98	10/15/98	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	O
blocker	blocker	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NNP	B-NP	O
q.	q.	NNP	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
exercised	exercise	VBD	B-VP	O
three	three	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
fifteen	fifteen	CD	B-NP	O
seconds	second	NNS	I-NP	O
stopping	stop	VBG	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
leg	leg	NN	B-NP	O
pain	pain	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
106	106	CD	B-NP	O
,	,	,	O	O
peak	peak	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
150/80	150/80	CD	I-NP	O
,	,	,	O	O
frequent	frequent	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
in	in	IN	B-PP	O
couplets	couplet	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
81	81	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
180/70	180/70	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
infusion	infusion	NN	I-NP	O
with	with	IN	B-PP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
premature	premature	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
contractions	contraction	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
diagnostic	diagnostic	JJ	I-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
images	image	NNS	I-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
reversibility	reversibility	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
with	with	IN	B-PP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
conclusive	conclusive	JJ	I-ADJP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
out-patient	out-patient	JJ	I-NP	O
medicines	medicine	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ace	ace	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
,	,	,	O	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	B-DNA
Cardura	Cardura	NNP	I-NP	O
and	and	CC	O	O
amlodipine	amlodipine	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Zocor	Zocor	NNP	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
out-patient	out-patient	JJ	B-NP	O
echos	echo	NNS	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
his	his	PRP$	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
developing	develop	VBG	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
months	month	NNS	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
leg	leg	NN	I-NP	O
pain	pain	NN	I-NP	O
completely	completely	RB	B-ADVP	O
resolves	resolve	VBZ	B-VP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
hypercoagulability	hypercoagulability	NN	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
out-patient	out-patient	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
with	with	IN	B-PP	O
enoxaparin	enoxaparin	NN	B-NP	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
bridge	bridge	NN	I-NP	O
to	to	TO	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	B-protein
until	until	IN	B-PP	I-protein
his	his	PRP$	B-NP	I-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
goal	goal	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
between	between	IN	B-NP	O
3	3	CD	I-NP	O
and	and	CC	I-NP	O
3.8	3.8	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
visiting	visit	VBG	I-VP	O
nurse	nurse	NN	B-NP	O
teach	teach	VB	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
the	the	DT	B-NP	O
enoxaparin	enoxaparin	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
come	come	VB	I-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
SHAVA	SHAVA	NNP	B-NP	O
HEALTHCARE	HEALTHCARE	NNP	I-NP	O
every	every	DT	B-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
level	level	NN	I-NP	O
checked	check	VBD	B-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
pelvic	pelvic	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
on	on	IN	B-PP	O
8/14/98	8/14/98	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
to	to	TO	B-VP	O
reevaluate	reevaluate	VB	I-VP	O
his	his	PRP$	B-NP	O
kidneys	kidney	NNS	I-NP	O
and	and	CC	O	O
rule	rule	VB	B-VP	O
out	out	RP	B-PRT	O
renal	renal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Cardura	Cardura	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
sublingual	sublingual	JJ	I-NP	I-protein
tablets	tablet	NNS	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
5	5	CD	B-NP	I-protein
minutes	minute	NNS	I-NP	I-protein
p.r.n.	p.r.n.	RB	B-NP	I-protein
chest	ch	JJS	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
indomethacin	indomethacin	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Axid	Axid	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
enoxaparin	enoxaparin	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

until	until	IN	B-SBAR	O
INR	INR	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
6	6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Darnell	Darnell	NNP	I-NP	O
Wanca	Wanca	NNP	I-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MONROE	MONROE	NNP	B-NP	O
RAABE	RAABE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
MX7	MX7	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ELLIS	ELLIS	NNP	B-NP	O
R.	R.	NNP	I-NP	O
MITCHELLE	MITCHELLE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
YT37	YT37	NNP	I-NP	O
XI057/8254	XI057/8254	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
58048	58048	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

PJHAOB6XVC	PJHAOB6XVC	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/7/98	10/7/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/25/98	5/25/98	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DENNIS	DENNIS	NNP	B-NP	O
L.	L.	NNP	I-NP	O
DAGGY	DAGGY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VF72	VF72	NNP	I-NP	O

